£113.03

This is the most expensive it has ever been. Walk away.

£113 today · previous high £113 · all-time low £103

Springer Myotonic Dystrophy: Disease Mechanism, Current Management and Therapeutic Development

Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 81 days · 81 data points (no recent data)

Historical
Generating forecast…
£113.03 £102.27 £104.62 £106.97 £109.31 £111.66 £114.01 11 August 2026 31 August 2026 20 September 2026 10 October 2026 30 October 2026
View at Amazon ↗

Price data last checked 10 day(s) ago - will refresh soon

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 81 days • 2 price levels

Days at Price
Current Price
56 days 25 days · current 0 14 28 42 56 £103 £113 Days at Price

Price Analysis

Most common price: £103 (56 days, 69.1%)

Price range: £103 - £113

Price levels: 2 different prices over 81 days

Description

This book provides an essential overview combining both clinical and fundamental research advances in myotonic dystrophy. The pathomechanism of myotonic dystrophy has long been unclear, but in the past decade, our understanding has shifted to a novel disease mechanism concept: “RNA disease”. Parallel to these advances in elucidating the pathophysiology, translational research is also progressing rapidly. The current challenge lies in assessing the effectiveness of treatment, and as such, there is a growing interest in observational studies of the disease’s various clinical symptoms. The book introduces readers to the molecular mechanisms within each organ and the resultant clinical features, which are presented together. In particular, it focuses on the central nervous system, since the pathology of the brain (central nervous system manifestation) has rarely been addressed systematically and will pose a persistent challenge, even if therapies have greatly advanced in the future. In addition, the book addresses the latest developments, such as research using patient-derived iPS cells and therapeutic research. Myotonic Dystrophy provides essential information for neurologists and researchers with an interest in muscle disease, including muscular dystrophy. Furthermore, since the disease involves various complications of the brain, heart, metabolism, etc., the book will be of great value to clinicians and researchers in the cardiovascular sciences, endocrinology, diabetes, dementia, and neuropsychology, as well as genetic specialists.

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
12 November 2018
Listed Since
11 April 2018

Barcode

No barcode data available

Similar Products You Might Like

Translational Research in Muscular Dystrophy
88% match

Translational Research in Muscular Dystrophy

Springer

£88.21 30 Oct 2026
Muscle Gene Therapy
84% match

Muscle Gene Therapy

Springer

£129.99 24 Oct 2026
Cardiorespiratory Aspects of Duchenne Muscular Dystrophy: New Perspectives and Controversies
83% match

Cardiorespiratory Aspects of Duchenne Muscular Dystrophy: New Perspectives and Controversies

Elsevier

£119.57 23 Oct 2026
RNA Metabolism in Neurodegenerative Diseases: 20 (Advances in Neurobiology, 20)
83% match

RNA Metabolism in Neurodegenerative Diseases: 20 (Advances in Neurobiology, 20)

Springer

£76.42 30 Aug 2026
Myotonic Dystrophy: Disease Mechanism, Current Management and Therapeutic Development
82% match

Myotonic Dystrophy: Disease Mechanism, Current Management and Therapeutic Development

Springer

£80.67 27 Oct 2026
Atlas of Neuromuscular Diseases: A Practical Guideline
82% match

Atlas of Neuromuscular Diseases: A Practical Guideline

Springer

£141.67 23 Oct 2026
Mitochondrial Dynamics and Neurodegeneration
82% match

Mitochondrial Dynamics and Neurodegeneration

Springer

£113.76 24 Oct 2026
Movement Disorders Rehabilitation
81% match

Movement Disorders Rehabilitation

Springer

£85.16 26 Oct 2026
Movement Disorders Rehabilitation
81% match

Movement Disorders Rehabilitation

Springer

£74.72 21 Oct 2026
Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers
81% match

Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers

Springer

£97.49 17 Oct 2026
Duchenne Muscular Dystrophy: Methods and Protocols: 1687 (Methods in Molecular Biology, 1687)
81% match

Duchenne Muscular Dystrophy: Methods and Protocols: 1687 (Methods in Molecular Biology, 1687)

Humana

£80.88 01 Nov 2026
Regenerative Medicine for Degenerative Muscle Diseases (Stem Cell Biology and Regenerative Medicine)
81% match

Regenerative Medicine for Degenerative Muscle Diseases (Stem Cell Biology and Regenerative Medicine)

Humana

£103.27 24 Oct 2026
Movement Disorders Curricula
80% match

Movement Disorders Curricula

Springer

£94.61 21 Oct 2026
Muscular Dystrophy: Methods and Protocols: 43 (Methods in Molecular Medicine, 43)
80% match

Muscular Dystrophy: Methods and Protocols: 43 (Methods in Molecular Medicine, 43)

Humana

£81.74 24 Oct 2026
Mitochondrial Respiratory Chain Disorders: From Clinical Presentation to Diagnosis and Treatment
80% match

Mitochondrial Respiratory Chain Disorders: From Clinical Presentation to Diagnosis and Treatment

£84.99 08 Sep 2026
Movement Disorders in Clinical Practice
80% match

Movement Disorders in Clinical Practice

Springer

£39.99 27 Oct 2026
Genetic Cardiomyopathies: A Clinical Approach
80% match

Genetic Cardiomyopathies: A Clinical Approach

Springer

£88.21 09 Sep 2026
Neurodevelopmental Disorders: Employing iPSC Technologies to Define and Treat Childhood Brain Diseases: 25 (Advances in Neurobiology, 25)
80% match

Neurodevelopmental Disorders: Employing iPSC Technologies to Define and Treat Childhood Brain Diseases: 25 (Advances in Neurobiology, 25)

Springer

£109.71 24 Oct 2026
Schwann Cell Development and Pathology
80% match

Schwann Cell Development and Pathology

Springer

£80.67 23 Oct 2026
Multiple System Atrophy
80% match

Multiple System Atrophy

Springer

£76.04 22 Oct 2026
Pathogenesis of Neurodegenerative Disorders (Contemporary Neuroscience)
80% match

Pathogenesis of Neurodegenerative Disorders (Contemporary Neuroscience)

Humana

£147.14 22 Oct 2026
Molecular Basis of Multiple Sclerosis: The Immune System: 51 (Results and Problems in Cell Differentiation, 51)
79% match

Molecular Basis of Multiple Sclerosis: The Immune System: 51 (Results and Problems in Cell Differentiation, 51)

Springer

£142.86 26 Oct 2026
Myopathies, An Issue of Neurologic Clinics (Volume 32-3) (The Clinics: Radiology, Volume 32-3)
79% match

Myopathies, An Issue of Neurologic Clinics (Volume 32-3) (The Clinics: Radiology, Volume 32-3)

Elsevier

£46.66 06 Nov 2026
Moyamoya Disease Update
79% match

Moyamoya Disease Update

Springer

£114.27 03 Nov 2026